维普期刊资源整合服务平台（V6.5）

283篇 您的检索式：作者名="Guilhot"

选中清除导出查看参考文献查看引证文献引用追踪共15页首页上一页第1页下一页末页 /15 跳转

	题名	作者	年代	出处	被引量
1	European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013显示文摘	Michele Baccarani Michael W. Deininger Gianantonio Rosti Andreas Hochhaus Simona Soverini Jane F. Apperley Francisco Cervantes Richard E. Clark Jorge E. Cortes Fran?ois Guilhot Henrik Hjorth-Hansen Timothy P. Hughes Hagop M. Kantarjian Dong-Wook Kim Richa	2013	Blood2013，，6：	3
2	Expression and activity of G protein-coupled receptor kinases in differentiated thyroid carci-noma显示文摘	MétayéT Menet E Guilhot J Kraimps JL	2002	J Clin Endocrinol Metab2002，87，7：	1
3	Preparation of polycrystal- line yttrium iron garnet ceramics 显示文摘	Grossean P Bachiorrini A Guilhot B	1997	Power Technology1997，13，：	1
4	Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia显示文摘	O'Brien S G Guilhot F Larson R A		New England Journal of Medicine0，，：	1
5	Interlukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a post-transcriptional mechanism显示文摘	Guidotte LG Chisari FV	1993	J Virol1993，67，：	1
6	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia显示文摘	Druker BJ Guilhot F O'Brien SG		0，，：	1
7	Influence of finely ground limestone on cement hydration显示文摘	Pera J Husson S Guilhot B		0，，02：	1
8	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia 显示文摘	Druker B J Guilhot F O' Brien SG	2006	N Engl J Med2006，355，23：	1
9	Indications for imatinib mesylate therapy and clinical management 显示文摘	Guilhot F	2004	Oncologist2004，9，3：	1
10	Imatinib compared with interferon and low-dose eytarabine for newly diagnosed chronic-phase chronic myeloid leukemia 显示文摘	O'Brien SG Guilhot F Larson RA	2003	N Engl J Med2003，348，11：	1
11	Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia 显示文摘	Flamant S Ritchie W Guilhot J	2010	Haematologica2010，95，8：	1
12	Imatinib Pharmaeokineties and Its Correlation with Response and Safety in Chronic-phase Chronic Myeloid Leukemia: a Subanalysis of the IRIS Study显示文摘	Larson RA Druker B J Guilhot F	2008	Blood2008，111，8：	1
13	Phospholipases C are involved in the virulence of Myeobacterium tuberculosis显示文摘	Raynaud C Guilhot C Rauzier J	2002	Mol Microbiol2002，45，1：	1
14	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia 显示文摘	Dntker B J Guilhot F O' Brien SG	2006	N Engl J Med2006，355，23：	1
15	Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia显示文摘	Preudhomme C Guilhot J Nicolini FE		0，，：	1
16	Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecularremission for at least 2 years:the prospective, muhicentre Stop Imatinib (STIM) triM显示文摘	Mahon FX R6a D Guilhot J	2010	Lancet Oncol2010，11，：	1
17	Five-year follow-up of pa- tients receiving imatinib for chronic myeloid leukemia显示文摘	Druker B J Guilhot F OBrien SG	2006	N Engl J Med2006，355，23：	1
18	Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib显示文摘	Legros L Guilhot J Huault S	2014	Leuk Res2014，38，6：	1
19	Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase显示文摘	Kantarjian HM Larson RA Guilhot F	2009	Caneer2009，115，3：	1
20	HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antlgen epitopes during hepatitis B virus infection 显示文摘	Nayersina R Fowler P Guilhot S	1993	J Immunol1993，150，：	1

返回顶部每页显示：

共15页首页上一页第1页下一页末页 /15 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示